CLINICAL_TRIALS
trial_result
· 2018-02-06
Clinical Trial Update: Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol [Phase 3]
Summary
A Phase 3 study protocol evaluating imiquimod for residual or recurrent cervical intraepithelial neoplasia lesions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Erasmus Medical Center | Conditions: Cervical Intraepithelial Neoplasia | Phase 3 | Status: UNKNOWN